Search for the tumor-associated proteins of oral squamous cell carcinoma collected in Taiwan using proteomics strategy

Journal of Proteome Research

Volumn 10, Issue 5, 2011, Pages 2347-2358

  Liao, Kuo An ^a   Tsay, Yeou Guang ^b   Huang, Li Chien ^e   Huang, Hsuan Ying ^c   Li, Chien Feng ^a,d   Wu, Ting Feng ^e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^e SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

14 3 3 zeta; 2 DE; LC MS MS; NNMT; oral cancer; oral squamous cell carcinoma; proteomics

Indexed keywords

APOLIPOPROTEIN A1; BIOLOGICAL MARKER; NICOTINAMIDE METHYLTRANSFERASE; PROTEIN 14 3 3 ZETA; PROTEOME; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ANGIOGENESIS; APOPTOSIS; ARTICLE; BETEL NUT; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; DISEASE SPECIFIC SURVIVAL; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; LIPID METABOLISM; LOCAL RECURRENCE FREE SURVIVAL; MALE; MASS SPECTROMETRY; MOUTH CARCINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEOMICS; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TAIWAN; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; VALIDATION PROCESS;

14-3-3 PROTEINS; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; ISOELECTRIC FOCUSING; MOUTH NEOPLASMS; NICOTINAMIDE N-METHYLTRANSFERASE; PROTEOMICS; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TAIWAN;

EID: 79955811782     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr101146w     Document Type: Article

References (86)

1. Kademani, D. Oral cancer Mayo Clin. Proc. 2007, 82, 878-887 (Pubitemid 47015470)
2. Ko, Y. C.; Huang, Y. L.; Lee, C. H.; Chen, M. J.; Lin, L. M.; Tsai, C. C. Betel Quid chewing, cigarette smoking, and alcohol consumption related to oral cancer in Taiwan J. Oral Pathol. Med. 1995, 24, 450-453
3. Jin, Y. T.; Tsai, S. T.; Wong, T. Y.; Chen, F. F.; Chen, R. M. Studies on promoting activity of Taiwan betel quid ingredients in hamster buccal pouch carcinogenesis Eur. J. Cancer B Oral. Oncol. 1996, 32B, 343-346
4. Silverman, S. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge J. Am. Dent. Assoc. 2001, 132 (Suppl) 7S-11S
5. Hannon, L. M. Cancer of the oral cavity Semin. Oncol. Nurs. 1989, 5, 150-159
6. Kao, S. Y.; Tu, F. H.; Yang, J.; Lo, W. L.; Chang, C. S. An overview of the detection and screening of oral cancer and prevcancer Chin. J. Oral Maxillofac. 2001, 12, 91-99
7. Wang, C. Q.; Qu, X.; Zhang, X. Y.; Zhou, C. J.; Liu, G. X.; Dong, Z. Q.; Wei, F. C.; Sun, S. Z. Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue Oral Oncol. 2010, 46, 65-69
8. Emanuelli, M.; Santarelli, A.; Sartini, D.; Ciavarella, D.; Rossi, V.; Pozzi, V.; Rubini, C.; Lo Muzio, L. Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma Histol. Histopathol. 2010, 25, 15-20
9. Zhang, L.; Yang, X.; Zhong, L.-P.; Zhou, X.-J.; Pan, H.-Y.; Wei, K.-J.; Li, J.; Chen, Z.-Y.; Zhang, Z.-Y. Decreased expression of Annexin AI correlates with pathologic differentiation grade in oral squamous cell carcinoma J. Oral Pathol. Med. 2009, 38, 362-370
10. Liu, S. Y.; Liu, Y. C.; Huang, W. T.; Huang, G. C.; Chen, T. C.; Lin, M. H. Up-regulation of matrix metalloproteinase-8 by betel quid extract and arecoline and its role in 2D motility Oral Oncol. 2007, 43, 1026-1033
11. Belbin, T. J.; Singh, B.; Barber, I.; Socci, N.; Wenig, B.; Smith, R.; Prystowsky, M. B.; Childs, G. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays Cancer Res. 2002, 62, 1184-1190 (Pubitemid 34160307)
12. Al Moustafa, A. E.; Alaoui-Jamali, M. A.; Batist, G.; Hernandez-Perez, M.; Serruya, C.; Alpert, L.; Black, M. J.; Sladek, R.; Foulkes, W. D. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells Oncogene 2002, 21, 2634-2640 (Pubitemid 34478321)
13. Moriya, T.; Seki, N.; Shimada, K.; Kato, M.; Yakushiji, T.; Nimura, Y.; Uzawa, K.; Takiguchi, M.; Tanzawa, H. In-house cDNA microarray analysis of gene expression profiles involved in SCC cell lines Int. J. Mol. Med. 2003, 12, 429-435
14. He, Q. Y.; Chen, J.; Kung, H. F.; Yuen, A. P.; Chiu, J. F. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics Proteomics 2004, 4, 271-278 (Pubitemid 38140892)
15. Koike, H.; Uzawa, K.; Nakashima, D.; Shimada, K.; Kato, Y.; Higo, M.; Kouzu, Y.; Endo, Y.; Kasamatsu, A.; Tanzawa, H. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach Int. J. Oncol. 2005, 27, 59-67
16. Turhani, D.; Krapfenbauer, K.; Thurnher, D.; Langen, H.; Fountoulakis, M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis Electrophoresis 2006, 27, 1417-1423
17. Cho, W. C. Contribution of oncoproteomics to cancer biomarker discovery Mol. Cancer 2007, 6, 25
18. Wu, T.-F.; Ku, W.-L.; Tsay, Y.-G. Proteome-based diagnostics and prognosis of bladder transitional cell carcinoma Expert Rev. Proteomics 2007, 4, 639-647 (Pubitemid 47623433)
19. Wang, Z.; Jiang, L.; Huang, C.; Li, Z.; Chen, L.; Gou, L.; Chen, P.; Tong, A.; Tang, M.; Gao, F.; Shen, J.; Zhang, Y.; Bai, J.; Zhou, M.; Miao, D.; Chen, Q. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma Mol. Cell. Proteomics 2008, 7, 1639-50
20. Onda, T.; Uzawa, K.; Nakashima, D.; Saito, K.; Iwadate, Y.; Seki, N.; Shibahara, T.; Tanzawa, H. Lin-7C/VELI3/MALS-3: an essential component in metastasis of human squamous cell carcinoma Cancer Res. 2007, 67, 9643-9648 (Pubitemid 47621210)
21. Khan, M. H.; Yasuda, M.; Higashino, F.; Haque, S.; Kohgo, T.; Nakamura, M.; Shindoh, M. nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression Am. J. Pathol. 2001, 158, 1785-1791 (Pubitemid 32422943)
22. Diamond, M. E.; Sun, L.; Ottaviano, A. J.; Joseph, M. J.; Munshi, H. G. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium J. Cell Sci. 2008, 121, 2197-2207
23. Sun, R.; Zhang, J. G.; Guo, C. B. Establishment of cervical lymph node metastasis model of squamous cell carcinoma in the oral cavity in mice Chin. Med. J. (Beijing, China, Engl. Ed.) 2008, 121, 1891-1895
24. Sheng, K.-H.; Yao, Y.-C.; Chuang, S.-S.; Wu, H.; Wu, T.-F. Search for the tumor-related proteins of transitional cell carcinoma in Taiwan by proteomic analysis Proteomics 2006, 6, 1058-1065 (Pubitemid 43260230)
25. Li, C. F.; Shen, K. H.; Huang, L. C.; Huang, H. Y.; Wang, Y. H.; Wu, T. F. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma Pathology 2010, 42, 43-49
26. Baumann, M. H.; Wisniewski, T.; Levy, E.; Plant, G. T.; Ghiso, J. C-terminal fragments of alpha- and beta-tubulin form amyloid fibrils in vitro and associate with amyloid deposits of familial cerebral amyloid angiopathy, British type Biochem. Biophys. Res. Commun. 1996, 219, 238-242
27. van Roy, F.; Berx, G. The cell-cell adhesion molecule E-cadherin Cell. Mol. Life Sci. 2008, 65, 3756-3788
28. Filiz, A. I.; Senol., Z.; Sucullu, I.; Kurt, Y.; Demirbas, S.; Levhi Akin, M. The survival effect of E-cadherin and catenins in colorectal carcinoma Colorectal Dis. 2010, 12, 1223-1230
29. Luque-García, J. L.; Martínez-Torrecuadrada, J. L.; Epifano, C.; Cañamero, M.; Babel, I.; Casal, J. I. Differential protein expression on the cell surface of colorectal cancer cells associated to tumor metastasis Proteomics 2010, 10, 940-952
30. van Oort, I. M.; Tomita, K.; van Bokhoven, A.; Bussemakers, M. J.; Kiemeney, L. A.; Karthaus, H. F.; Witjes, J. A.; Schalken, J. A. The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study Prostate 2007, 67, 1432-1438 (Pubitemid 47435789)
31. Clairotte, A.; Lascombe, I.; Fauconnet, S.; Mauny, F.; Félix, S.; Algros, M. P.; Bittard, H.; Kantelip, B. Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors Am. J. Clin. Pathol. 2006, 125, 119-126 (Pubitemid 43089734)
32. Kashibuchi, K.; Tomita, K.; Schalken, J. A.; Kume, H.; Yamaguchi, T.; Muto, S.; Horie, S.; Kitamura, T. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract Eur. Urol. 2006, 49, 839-845
33. Endo, K.; Ueda, T.; Ueyama, J.; Ohta, T.; Terada, T. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival Hum. Pathol. 2000, 31, 558-565 (Pubitemid 30323980)
34. Närkiö-Mäkelä, M.; Pukkila, M.; Lagerstedt, E.; Virtaniemi, J.; Pirinen, R.; Johansson, R.; Kosunen, A.; Lappalainen, K.; Hämäläinen, K.; Kosma, V. M. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma Arch. Otolaryngol. Head Neck Surg. 2009, 135, 1035-1040
35. Ueda, G.; Sunakawa, H.; Nakamori, K.; Shinya, T.; Tsuhako, W.; Tamura, Y.; Kosugi, T.; Sato, N.; Ogi, K.; Hiratsuka, H. Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma Int. J. Oral Maxillofac. Surg. 2006, 35, 356-361 (Pubitemid 43286269)
36. Savagner, P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition Bioessays 2001, 23, 912-923 (Pubitemid 32972691)
37. Guarino, M.; Rubino, B.; Ballabio, G. The role of epithelial-mesenchymal transition in cancer pathology Pathology 2007, 39, 305-318 (Pubitemid 46897605)
38. Cunningham, T. D.; Jiang, X.; Shapiro, D. J. Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity Cell Immunol. 2007, 245, 32-41 (Pubitemid 46805070)
39. Bladergroen, B. A.; Meijer, C. J.; ten Berge, R. L.; Hack, C. E.; Muris, J. J.; Dukers, D. F.; Chott, A.; Kazama, Y.; Oudejans, J. J.; van Berkum, O.; Kummer, J. A. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 2002, 99, 232-237
40. Rousalova, I.; Krepela, E.; Prochazka, J.; Cermak, J.; Benkova, K. Expression of proteinase inhibitor-9/serpinB9 in non-small cell lung carcinoma cells and tissues Int. J. Oncol. 2010, 36, 275-283
41. Bossard, C.; Belhadj, K.; Reyes, F.; Martin-Garcia, N.; Berger, F.; Kummer, J. A.; Briê're, J.; Baglin, A. C.; Cheze, S.; Bosq, J.; Ribrag, V.; Gisselbrecht, C.; Mounier, N.; Gaulard, P. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials Blood 2007, 109, 2183-2189 (Pubitemid 46348221)
42. van Houdt, I. S.; Oudejans, J. J.; van den Eertwegh, A. J.; Baars, A.; Vos, W.; Bladergroen, B. A.; Rimoldi, D.; Muris, J. J.; Hooijberg, E.; Gundy, C. M.; Meijer, C. J.; Kummer, J. A. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma Clin. Cancer Res. 2005, 11, 6400-6407 (Pubitemid 41262972)
43. Petrache, I.; Fijalkowska, I.; Zhen, L.; Medler, T. R.; Brown, E.; Cruz, P.; Choe, K. H.; Taraseviciene-Stewart, L.; Scerbavicius, R.; Shapiro, L.; Zhang, B.; Song, S.; Hicklin, D.; Voelkel, N. F.; Flotte, T.; Tuder, R. M. A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema Am. J. Respir. Crit. Care Med. 2006, 173, 1222-1228 (Pubitemid 43848392)
44. Chawla, R. K.; Lawson, D. H.; Sarma, P. R.; Nixon, D. W.; Travis, J. Serum alpha-1 proteinase inhibitor in advanced cancer: mass variants and functionally inert forms Cancer Res. 1987, 47, 1179-1184 (Pubitemid 17027949)
45. Tountas, Y.; Sparos, L.; Theodoropoulos, C.; Trichopoulos, D. Alpha 1-antitrypsin and cancer of the pancreas Digestion 1985, 31, 37-40
46. Bohman, S.; Matsumoto, T.; Suh, K.; Dimberg, A.; Jakobsson, L.; Yuspa, S.; Claesson-Welsh, L. Proteomic analysis of vascular endothelial growth factor-induced endothelial cell differentiation reveals a role for chloride intracellular channel 4 (CLIC4) in tubular morphogenesis J. Biol. Chem. 2005, 280, 42397-42404 (Pubitemid 43023212)
47. Tung, J. J.; Hobert, O.; Berryman, M.; Kitajewski, J. Chloride intracellular channel 4 is involved in endothelial proliferation and morphogenesis in vitro Angiogenesis 2009, 12, 209-220
48. Suh, K. S.; Malik, M.; Shukla, A.; Yuspa, S. H. CLIC4, skin homeostasis and cutaneous cancer: surprising connections Mol. Carcinog. 2007, 46, 599-604 (Pubitemid 47255174)
49. Yao, Q.; Qu, X.; Yang, Q.; Wei, M.; Kong, B. CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer Oncol. Rep. 2009, 22, 541-548
50. Suh, K. S.; Mutoh, M.; Gerdes, M.; Yuspa, S. H. CLIC4, an intracellular chloride channel protein, is a novel molecular target for cancer therapy J. Investig. Dermatol. Symp. Proc. 2005, 10, 105-109
51. Vellaichamy, A.; Sreekumar, A.; Strahler, J. R.; Rajendiran, T.; Yu, J.; Varambally, S.; Li, Y.; Omenn, G. S.; Chinnaiyan, A. M.; Nesvizhskii, A. I. Proteomic interrogation of androgen action in prostate cancer cells reveals roles of aminoacyl tRNA synthetases PLoS One 2009, 4, e7075
52. Voges, D.; Zwickl, P.; Baumeister, W. The 26S proteasome: a molecular machine designed for controlled proteolysis Annu. Rev. Biochem. 1999, 68, 1015-1068 (Pubitemid 29449214)
53. Mazumdar, T.; Gorgun, F. M.; Sha, Y.; Tyryshkin, A.; Zeng, S.; Hartmann-Petersen, R.; Jørgensen, J. P.; Hendil, K. B.; Eissa, N. T. Regulation of NF-kappaB activity and inducible nitric oxide synthase by regulatory particle non-ATPase subunit 13 (Rpn13) Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 13854-13859
54. Yan, M.; Xu, Q.; Zhang, P.; Zhou, X. J.; Zhang, Z. Y.; Chen, W. T. Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma BMC Cancer 2010, 10, 437
55. Mani, A.; Gelmann, E. P. The ubiquitin-proteasome pathway and its role in cancer J. Clin. Oncol. 2005, 23, 4776-4789 (Pubitemid 46224082)
56. Chae, H. Z.; Chung, S. J.; Rhee, S. G. Thioredoxin-dependent peroxide reductase from yeast J. Biol. Chem. 1994, 269, 27670-27678 (Pubitemid 24346604)
57. Jin, D. Y.; Chae, H. Z.; Rhee, S. G.; Jeang, K. T. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation J. Biol. Chem. 1997, 272, 30952-30961 (Pubitemid 27527539)
58. Park, H. J.; Kim, B. G.; Lee, S. J.; Heo, S. H.; Kim, J. Y.; Kwon, T. H.; Lee, E. B.; Ryoo, H. M.; Cho, J. Y. Proteomic profiling of endothelial cells in human lung cancer J. Proteome Res. 2008, 7, 1138-1150
59. Pritchard, C.; Mecham, B.; Dumpit, R.; Coleman, I.; Bhattacharjee, M.; Chen, Q.; Sikes, R. A.; Nelson, P. S. Conserved gene expression programs integrate mammalian prostate development and tumorigenesis Cancer Res. 2009, 69, 1739-1747
60. Li, M.; Lin, Y. M.; Hasegawa, S.; Shimokawa, T.; Murata, K.; Kameyama, M.; Ishikawa, O.; Katagiri, T.; Tsunoda, T.; Nakamura, Y.; Furukawa, Y. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray Int. J. Oncol. 2004, 24, 305-312
61. Jang, J. S.; Cho, H. Y.; Lee, Y. J.; Ha, W. S.; Kim, H. W. The differential proteome profile of stomach cancer: identification of the biomarker candidates Oncol. Res. 2004, 14, 491-499 (Pubitemid 39551562)
62. Mold, C.; Baca, R.; Du Clos., T. W. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors J. Autoimmun. 2002, 19, 147-154 (Pubitemid 35341864)
63. Gaipl, U. S.; Sheriff, A.; Franz, S.; Munoz, L. E.; Voll, R. E.; Kalden, J. R.; Herrmann, M. Inefficient clearance of dying cells and autoreactivity Curr. Top. Microbiol. Immunol. 2006, 305, 161-176 (Pubitemid 47400269)
64. Levo, Y.; Wollner, S.; Treves, A. J. Serum amyloid P-component levels in patients with malignancy Scand. J. Immunol. 1986, 24, 147-151 (Pubitemid 16022371)
65. Aksoy, S.; Szumlanski, C. L.; Weinshilboum, R. M. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization J. Biol. Chem. 1994, 269, 14835-14840
66. Wu, Y.; Siadaty, M. S.; Berens, M. E.; Hampton, G. M.; Theodorescu, D. Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration Oncogene 2008, 27, 6679-6689
67. Sartini, D.; Muzzonigro, G.; Milanese, G.; Pierella, F.; Rossi, V.; Emanuelli, M. Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma J. Urol. 2006, 176, 2248-2254 (Pubitemid 44633146)
68. Emanuelli, M.; Santarelli, A.; Sartini, D.; Ciavarella, D.; Rossi, V.; Pozzi, V.; Rubini, C.; Lo Muzio, L. Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma Histol. Histopathol. 2010, 25, 15-20
69. Sahoo, D.; Trischuk, T. C.; Chan, T.; Drover, V. A.; Ho, S.; Chimini, G.; Agellon, L. B.; Agnihotri, R.; Francis, G. A.; Lehner, R. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes J. Lipid Res. 2004, 45, 1122-1131 (Pubitemid 38679508)
70. Lo, W. Y.; Lai., C. C.; Hua, C. H.; Tsai, M. H.; Huang, S. Y.; Tsai, C. H.; Tsai, F. J. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining J. Proteome Res. 2007, 6, 2143-2151
71. Fujii, S.; Koga, S.; Shono, T.; Yamamoto, K.; Ibayashi, H. Serum apoprotein A-I and A-II levels in liver diseases and cholestasis Clin. Chim. Acta 1981, 115, 321-331 (Pubitemid 11052484)
72. Hachem, H.; Favre, G.; Raynal, G.; Blavy, G.; Canal, P.; Soula, G. Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosis J. Clin. Chem. Clin. Biochem. 1986, 24, 161-166 (Pubitemid 16124081)
73. Aitken, A. 14-3-3 proteins: a historic overview Semin. Cancer Biol. 2006, 16, 162-172 (Pubitemid 43796128)
74. Porter, G. W.; Khuri, F. R.; Fu, H. Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways Semin. Cancer Biol. 2006, 16, 193-202 (Pubitemid 43796125)
75. Muslin, A. J.; Tanner, J. W.; Allen, P. M.; Shaw, A. S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine Cell 1996, 84, 889-897 (Pubitemid 26106858)
76. Pozuelo Rubio, M.; Geraghty, K. M.; Wong, B. H.; Wood, N. T.; Campbell, D. G.; Morrice, N.; Mackintosh, C. 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking Biochem. J. 2004, 379 (Pt 2) 395-408 (Pubitemid 38570113)
77. Qi, W.; Liu, X.; Qiao, D.; Martinez, J. D. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues Int. J. Cancer 2005, 113, 359-363 (Pubitemid 40038701)
78. Danes, C. G.; Wyszomierski, S. L.; Lu, J.; Neal, C. L.; Yang, W.; Yu, D. 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling Cancer Res. 2008, 68, 1760-1767 (Pubitemid 351416561)
79. Bajpai, U.; Sharma, R.; Kausar, T.; Dattagupta, S.; Chattopadhayay, T. K.; Ralhan, R. Clinical significance of 14-3-3 zeta in human esophageal cancer Int. J. Biol. Markers 2008, 23, 231-237
80. Macdonald, A.; Campbell, D. G.; Toth, R.; McLauchlan, H.; Hastie, C. J.; Arthur, J. S. Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL BMC Cell Biol. 2006, 7, 1
81. Zha, J.; Harada, H.; Yang, E.; Jockel, J.; Korsmeyer, S. J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) Cell 1996, 87, 619-628 (Pubitemid 26386936)
82. Niemantsverdriet, M.; Wagner, K.; Visser, M.; Backendorf, C. Cellular functions of 14-3-3 zeta in apoptosis and cell adhesion emphasize its oncogenic character Oncogene 2008, 27, 1315-1319 (Pubitemid 351294692)
83. Li, Z.; Zhao, J.; Du, Y.; Park, H. R.; Sun, S. Y.; Bernal-Mizrachi, L.; Aitken, A.; Khuri, F. R.; Fu, H. Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation Proc. Natl. Acad. Sci. 2008, 105, 162-167
84. Danes, C. G.; Wyszomierski, S. L.; Lu, J.; Neal, C. L.; Yang, W.; Yu, D. 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling Cancer Res. 2008, 68, 1760-1767 (Pubitemid 351416561)
85. Arora, S.; Matta, A.; Shukla, N. K.; Deo, S. V.; Ralhan, R. Identification of differentially expressed genes in oral squamous cell carcinoma Mol. Carcinog. 2005, 42, 97-108
86. Matta, A.; Bahadur, S.; Duggal, R.; Gupta, S. D.; Ralhan, R. Over-expression of 14-3-3zeta is an early event in oral cancer BMC Cancer 2007, 7, 169